Government Gazette website http://www.ratchakitcha.soc.go.th/ Order of the Ministry of Public Health No. 1435/2560 regarding the revocation of the drug formula registration
with academic information that Phenylbutazone (Phenylbutazone) has been the cause of serious adverse reactions. This may cause anemia from bone marrow atrophy (aplastic anaemia) and low white blood cell count. (agranulocytosis), which can be life-threatening
Therefore, by virtue of Section 86 of the Drug Act, B.E. 2510 (1967), as amended by the Drug Act (No. 5), B.E. No. 1/2017, on 11 January 2017, there was an order revoking the registration of drug formulations for humans containing phenylbutazone. (Phenylbutazone) is a component of 70 formulas as per the attached list.
In addition, if any licensee does not agree with this order can exercise the right to file a lawsuit with the Administrative Court by submitting a plaint in writing by registered mail to the Administrative Court within ninety days from the date of receipt of this order.
From now on
Ordered on 29 September 2017
Piyasakon Sakolsatayathorn
Minister of Health
